183 related articles for article (PubMed ID: 27983878)
21. Implications of enterotoxigenic Escherichia coli genomics for vaccine development.
Sjöling Å; von Mentzer A; Svennerholm AM
Expert Rev Vaccines; 2015 Apr; 14(4):551-60. PubMed ID: 25540974
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and Genotypic Characterization of Clinical Enterotoxigenic Escherichia coli Isolates from Shenzhen, China.
Li Y; Luo Q; Shi X; Lin Y; Qiu Y; Lv D; Jiang Y; Chen Q; Jiang M; Ma H; Cheng J; Hu Q
Foodborne Pathog Dis; 2017 Jun; 14(6):333-340. PubMed ID: 28537439
[TBL] [Abstract][Full Text] [Related]
23. Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.
Begum YA; Talukder KA; Azmi IJ; Shahnaij M; Sheikh A; Sharmin S; Svennerholm AM; Qadri F
PLoS One; 2016; 11(7):e0157415. PubMed ID: 27428376
[TBL] [Abstract][Full Text] [Related]
24. Growth performance and gastrointestinal microbial ecology responses of piglets receiving Saccharomyces cerevisiae fermentation products after an oral challenge with Escherichia coli (K88).
Kiarie E; Bhandari S; Scott M; Krause DO; Nyachoti CM
J Anim Sci; 2011 Apr; 89(4):1062-78. PubMed ID: 21148775
[TBL] [Abstract][Full Text] [Related]
25. Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K88.
Yang KM; Jiang ZY; Zheng CT; Wang L; Yang XF
J Anim Sci; 2014 Apr; 92(4):1496-503. PubMed ID: 24492550
[TBL] [Abstract][Full Text] [Related]
26. Screening of probiotic candidates in a simulated piglet small intestine in vitro model.
Hansen LHB; Cieplak T; Nielsen B; Zhang Y; Lauridsen C; Canibe N
FEMS Microbiol Lett; 2021 May; 368(7):. PubMed ID: 33877306
[TBL] [Abstract][Full Text] [Related]
27. Colonization factors of enterotoxigenic Escherichia coli.
Madhavan TP; Sakellaris H
Adv Appl Microbiol; 2015; 90():155-97. PubMed ID: 25596032
[TBL] [Abstract][Full Text] [Related]
28. Effects of dietary supplementation of bacteriophages against enterotoxigenic Escherichia coli (ETEC) K88 on clinical symptoms of post-weaning pigs challenged with the ETEC pathogen.
Lee CY; Kim SJ; Park BC; Han JH
J Anim Physiol Anim Nutr (Berl); 2017 Feb; 101(1):88-95. PubMed ID: 27271838
[TBL] [Abstract][Full Text] [Related]
29. Vaccines against enterotoxigenic Escherichia coli.
Svennerholm AM; Tobias J
Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
[TBL] [Abstract][Full Text] [Related]
30. Effect of Lactobacillus plantarum CJLP243 on the growth performance and cytokine response of weaning pigs challenged with enterotoxigenic Escherichia coli.
Lee JS; Awji EG; Lee SJ; Tassew DD; Park YB; Park KS; Kim MK; Kim B; Park SC
J Anim Sci; 2012 Nov; 90(11):3709-17. PubMed ID: 22859771
[TBL] [Abstract][Full Text] [Related]
31. [Fimbriae of animal-originated enterotoxigenic Escherichia coli--a review].
Zhou H; Zhu J; Zhu G
Wei Sheng Wu Xue Bao; 2012 Jun; 52(6):679-86. PubMed ID: 22934347
[TBL] [Abstract][Full Text] [Related]
32. Real-Time TaqMan PCR Assay for the Detection of Heat-Labile and Heat-Stable Enterotoxin Genes in a Geographically Diverse Collection of Enterotoxigenic Escherichia coli Strains and Stool Specimens.
Pattabiraman V; Parsons MB; Bopp CA
Foodborne Pathog Dis; 2016 Apr; 13(4):212-20. PubMed ID: 26859628
[TBL] [Abstract][Full Text] [Related]
33. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
Zhang W; Sack DA
Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
[TBL] [Abstract][Full Text] [Related]
34. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
Xia P; Meng X; Zhu G
Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
[TBL] [Abstract][Full Text] [Related]
35. Status of vaccine research and development for enterotoxigenic Escherichia coli.
Bourgeois AL; Wierzba TF; Walker RI
Vaccine; 2016 Jun; 34(26):2880-2886. PubMed ID: 26988259
[TBL] [Abstract][Full Text] [Related]
36. Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges.
Wan MLY; Forsythe SJ; El-Nezami H
Crit Rev Food Sci Nutr; 2019; 59(20):3320-3333. PubMed ID: 29993263
[TBL] [Abstract][Full Text] [Related]
37. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
[TBL] [Abstract][Full Text] [Related]
38. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
39. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.
Meraz IM; Jiang ZD; Ericsson CD; Bourgeois AL; Steffen R; Taylor DN; Hernandez N; DuPont HL
J Travel Med; 2008; 15(6):412-8. PubMed ID: 19090795
[TBL] [Abstract][Full Text] [Related]
40. Comparison of conventional plating, PMA-qPCR, and flow cytometry for the determination of viable enterotoxigenic Escherichia coli along a gastrointestinal in vitro model.
Roussel C; Galia W; Leriche F; Chalancon S; Denis S; Van de Wiele T; Blanquet-Diot S
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9793-9802. PubMed ID: 30238141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
